Opportunities for DNA Microchip and Array Technologies


Regular Price: USD 3,950.00

Special Price USD 2,765.00

30% OFF

* Required Fields

Regular Price: USD 3,950.00

Special Price USD 2,765.00


Be the first to review this product

Table of Contents

Opportunities for DNA Microchip and Array Technologies, Executive SummaryIntroduction to the DNA Microarray MarketMarket OverviewReport Objectives and PurposeReport Scope and SegmentationReport Structure Analysis of the Major Market SegmentsOverall TrendsDNA Microarray Market DynamicsCompetitive OverviewCompetitive OverviewOpportunities for DNA Microchip and Array Technologies, Market Engineering Research MethodologyResearch SourcesSecondary SourcesPrimary ResearchMarket Engineering Challenges of the DNA Microarray Technology MarketsChallenges Facing the Microarray IndustryChallenges Facing the Microarray IndustryDevelopment and Production Costs Make This Technology Expensive and Out of Reach for Many End UsersInformatics Technologies Not Yet Sufficient for Dealing with the Large Amounts of Experimental Data ProducedLack of Industry StandardsPoor Reproducibility of Experimental ResultsDNA Microarray Technology Incorporates Multiple DisciplinesIntellectual Property Disputes Have Slowed the Availability and Adoption of DNA Microarray TechnologyScientists Often Prefer Hands-on TechnologiesCompetition from Non-Microarray Technologies for Polymorphism Screening and GenotypingSensitivity of Current Technologies Limits Applications in Quantitative Gene Expression AnalysisCurrently Available Microarray Densities Unable to Fit Entire Genomes on a Single Chip Market Engineering Research and Opportunities in the DNA Microarrays MarketMarket Overview and DefinitionsMarket OverviewMarket DefinitionTechnology OverviewTechnology OverviewSolid-Support TechnologyStructural and Functional GenomicsExpression ProfilingPolymorphism DiscoveryGenotyping and DiagnosticsMarket DriversMarket DriversAffymetrix Has Expanded Its Gene Chip Manufacturing CapacityAvailability of Spotting Technologies Is Increasing Penetration of the Academic MarketIncreasing Prices for Spotting InstrumentsRefined Protocols and Increasing Wisdom Make Array Technology More User-FriendlyExplosion in Sequence Data Offers Up Targets for MicroarraysNew Applications Provide Additional Opportunities for ChipsInformatics and Software Needs Are Being AddressedAffymetrix' Easy-Access Program Is Driving Utilization of GeneChipsDiagnostics and Disease MonitoringNew Chip Technologies and Integrated ApplicationsMarket RestraintsMarket RestraintsFalling Chip PricesCompetition from Alternative TechnologiesDissatisfaction with Array Data and Reproducibility Slowing Adoption Rates by Academic ResearchersIncreasing Saturation of the Microarray Spotters MarketInformatics Bottleneck Is Restraining Microarray UtilizationCompetition from Home-Brews Has Limited Sales of Commercial InstrumentsAdoption Rates Are Typically Slow for Emerging TechnologiesLong Development Phase for Cutting-Edge TechnologyIntellectual Property BattlesCost Containment in the Healthcare IndustryMarket Revenues and Future Opportunity for DNA Microarray TechnologyMarket Revenues and Future Opportunity for DNA Microarray TechnologyMicroarrays Market ForecastMicroarray Instrumentation Market ForecastDNA Microarray Industry and Technology TrendsEmphasis Is on Developing More Automated SystemsUniversity of Wisconsin Develops New Micromirror Array MethodSNP Chips Now a RealityAcademics Going the Way of Core FacilitiesCompetitive EnvironmentMarket PlayersOpportunities for DNA Microchip and Array Technologies, End-User Survey of DNA Microarray UseIntroductionIntroductionAlbert Einstein Medical School (1)Albert Einstein Medical School (2)Harvard UniversityKarolinska InstitutePenn State (1)Penn State (2)Rockefeller UniversityStanford University (1)Stanford University (2)Arizona Cancer Center/University of ArizonaUCLAUCSF (1)UCSF (2)UCSF (3)University of ChicagoUniversity of PennsylvaniaUniversity of Pennsylvania (Whistar Institute)University of TennesseeGovernment-Sponsored Research LabsFred Hutchison Cancer Research CenterNational Cancer Institute (NCI)National Human Genome Research Institute (NHGRI)National Institutes of Health (1)National Institutes of Health (2)Oak Ridge National LabPharmaceutical/Biotechnology Research LabsBoehringer IngelheimBristol-Myers SquibbGeneLogicGlaxo WellcomeHoechst Marion RousselMetabolexPfizerKey Findings and ConclusionsKey Findings and ConclusionsOpportunities for DNA Microchip and Array Technologies, Market Engineering StrategyStrategies for Research & DevelopmentChallenge 1: Informatics Technologies Are a Rate-Limiting Step in DNA Microarray UtilizationChallenge 2: Lack of Technology Standards and Experimental ProtocolsChallenge 3: Lack of Reproducibility in Experimental ResultsStrategies for the Marketing DepartmentChallenge 4: Development and Production Costs Make This Technology Expensive and Out of Reach for Many ResearchersChallenge 5: Scientists Often Prefer Hands-on TechnologiesChallenge 6: Competition from Non-Microarray Technologies for Polymorphism Discovery and Genotyping

Related Research

Release Date : 21-Nov-18

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.